Evaluation of the Clinical Performances of a Point of Care Analyzer Enabling Pre-transfusion ABOD Group Ultimate Verification at the Patient Bedside

Launched by FRANCIS CORAZZA · Apr 9, 2020

Keywords

ClinConnect Summary

ABO-incompatible red blood cell transfusions still represent an important hazard in transfusion medicine. Therefore, some countries have introduced a systematic bedside ABO agglutination test checking that the right blood is given to the right patient. However, this strategy is entirely manual, requires an extremely time-consuming learning program and relies on a subjective interpretation of agglutination on ABO test cards (for example Biorad, Diagast).

The ULB spinoff Antigon developed a prototype device on the basis of a technology developed in the Translational research laboratory of CH...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • For the device evaluation inside the laboratory : every patient for whom a blood group is ordered to the blood transfusion laboratory.
• • For the device bedside evaluation : each patient from the hematology unit (one day clinic) requiring a transfusion.
• Exclusion Criteria:
• • Emergency circumstances requiring an urgent transfusion
• • Patient older than 80 years old
• • Patients with venous access